Mayne Pharma Group
(ASX) MYX
Mayne Pharma Group Financials at a Glance
Market Cap
$230.74M
Revenue (TTM)
$820.64M
Net Income (TTM)
$212.46M
EPS (TTM)
$-1.02
P/E Ratio
-2.77
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$2.78
Volume
124,560
Open
$2.89
Price
$2.78
Volume
124,560
Open
$2.89
Previous Close
$2.78
Daily Range
$2.77 - $2.91
52-Week Range
$2.04 - $7.16
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$2.78
Volume
124,560
Open
$2.89
Previous Close
$2.78
Daily Range
$2.77 - $2.91
52-Week Range
$2.04 - $7.16
MYX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Mayne Pharma Group
Industry
Pharmaceuticals
Sector
Health CareEmployees
450
CEO
Shawn Patrick O'Brien
Website
www.maynepharma.comHeadquarters
Salisbury South, SA 5106, AU
MYX Financials
Key Financial Metrics (TTM)
Gross Margin
55%
Operating Margin
-11%
Net Income Margin
-20%
Return on Equity
-21%
Return on Capital
-7%
Return on Assets
-9%
Earnings Yield
-36.10%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$230.74M
Shares Outstanding
81.25M
Volume
124.56K
Avg. Volume
477.95K
Financials (TTM)
Gross Profit
$247.27M
Operating Income
$23.59M
EBITDA
$42.08M
Operating Cash Flow
$17.47M
Capital Expenditure
$12.28M
Free Cash Flow
$5.19M
Cash & ST Invst.
$100.40M
Total Debt
$41.27M
Mayne Pharma Group Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$212.07M
+12.8%
Gross Profit
$106.80M
+43.7%
Gross Margin
50.36%
N/A
Market Cap
$230.74M
N/A
Market Cap/Employee
$271.46K
N/A
Employees
850
N/A
Net Income
$14.94M
+78.8%
EBITDA
$5.81M
+115.8%
Quarterly Fundamentals
Net Cash
$22.73M
-80.8%
Accounts Receivable
$192.59M
-3.2%
Inventory
$47.50M
-48.3%
Long Term Debt
$4.31M
-87.0%
Short Term Debt
$40.31M
+481.2%
Return on Assets
-8.85%
N/A
Return on Invested Capital
-6.65%
N/A
Free Cash Flow
$9.37M
+77.4%
Operating Cash Flow
$8.06M
+68.0%